Skip to main content

Peer Review reports

From: ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1

Original Submission
12 Jan 2017 Submitted Original manuscript
6 Mar 2017 Reviewed Reviewer Report - Chung-Ta Lee
9 Mar 2017 Reviewed Reviewer Report - Anne Jarry
27 Aug 2017 Author responded Author comments - Xiaodong Jiao
Resubmission - Version 2
27 Aug 2017 Submitted Manuscript version 2
31 Aug 2017 Reviewed Reviewer Report - Anne Jarry
3 Sep 2017 Reviewed Reviewer Report - Chung-Ta Lee
11 Oct 2017 Author responded Author comments - Xiaodong Jiao
Resubmission - Version 3
11 Oct 2017 Submitted Manuscript version 3
4 Dec 2017 Reviewed Reviewer Report - Anne Jarry
30 Dec 2017 Author responded Author comments - Xiaodong Jiao
Resubmission - Version 4
30 Dec 2017 Submitted Manuscript version 4
26 Jan 2018 Author responded Author comments - Xiaodong Jiao
Resubmission - Version 5
26 Jan 2018 Submitted Manuscript version 5
13 Mar 2018 Author responded Author comments - Xiaodong Jiao
Resubmission - Version 6
13 Mar 2018 Submitted Manuscript version 6
Publishing
22 Mar 2018 Editorially accepted
18 May 2018 Article published 10.1186/s12885-018-4294-9

You can find further information about peer review here.

Back to article page